Healthcare Business

Rubius Therapeutics was one of Monday’s biggest winners after it announced initial data from its ongoing Phase 1/2 clinical trial of RTX-240 in patients with advanced solid tumors.
Altimmune has announced additional preclinical data in regards to its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.
Drugs, whether they are generic, OTC, or patented, are affordable to most Americans, particularly those who have healthcare that covers the cost of pharmaceuticals. However, in rare cases, drugs can...
Novavax stock jumped to close out the week after the firm announced the final efficacy numbers for its COVID-19 vaccine candidate.
BofA Securities feels these four top medtech companies are all poised for potential positive news and developments in the near future. These stocks could be good additions to growth portfolios...
Johnson & Johnson officially enters the fight against COVID-19 as its single-shot vaccine was approved over the weekend. It plans to deliver 100 million single-shot vaccines during the first half of...
Here are five notable health care laggard stocks that appear to have plenty of upside potential. Most of them are dividend payers too.
Rome was not built in a day, and neither are multibillion-dollar corporations. Biopharmaceuticals company AbbVie is the largest American company founded in the past decade.
Tilray shares jumped on Tuesday after the company announced that it would be expanding its operations into the United Kingdom.
Eli Lilly is shuffling the executive deck on Tuesday after allegations about inappropriate communication arose against its chief financial officer.
Despite significant strides in cancer detection and treatment, cancer remains a scary word. It’s certainly scarier than hearing you have a chronic condition. But the truth is that the potentially...
London-based Jazz Pharmaceuticals has agreed to pay $7.2 billion to acquire GW Pharmaceuticals, a maker of drugs derived from cannabis plants.
Gritstone pushed higher on Tuesday after the company reported that it was advancing the development of a second-generation vaccine against SARS-CoV-2.
Aclaris shares more than doubled to start out the week after the company announced positive results from its mid-stage rheumatoid arthritis study.
Lexicon Pharma shares jumped on Thursday morning after the company announced that it received regulatory feedback from the FDA regarding its heart failure treatment.